Affiliation:
1. Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan
Abstract
SUMMARY
Lymphokine-activated killer (LAK) cells generated by culture of peripheral blood mononuclear cells (PBMC). spleen cells (SPC) and regional lymph node cells (LNC) with IL-2 for 4 days were examined for their functional capabilities m 29 patients with gastric carcinoma. The cytotoxic activity of LAK cells induced from LNC was significantly lower than that from either PBMC or SPC. although there was no difference between PBMC or SPC. The induction of mRNA of interferon-gamma (IFN-γ) or tumour necrosis factor-alpha (TNF-α) and the production of these cytokines in the non-adherent LAK cells from LNC were also significantly reduced compared with those from PBMC or SPC. Further, the LAK cells from LNC secreted significantly lower levels of these cytokines when stimulated with tumour target, Raji cells, although the production of these cytokines was markedly increased by stimulation with the targets in all three cell populations. Phenotypic analysis of each cell population revealed a decreased proportion of the cells mediating natural killer (NK) activity, including CD16+. CD56+, and CD57+ cells in LNC either before or after culture, although OKIal+ and CD25+ cells were uniformly increased in all ceil populations after culture. Changes in subpopulations of CD4+ and CD8+ cells in LNC were not apparently different from PBMC or SPC. These results indicated the differential reactivity of each lymphocyte population to IL-2 and the reduced LAK cell function of LNC compared with PBMC or SPC in patients with gastric carcinoma.
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Reference41 articles.
1. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumour cells by mterleukin-2 activated autologous human peripheral blood lymphocytes;Grimm;J Exp Med,1982
2. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin 2 alone;Rosenberg;N Engl J Med,1987
3. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells;Gemlo;Cancer Res,1988
4. Induction of endogenous cytokine–mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients;Kasid;J Immunal,1989
5. Young HA. Cytokine gene expression during the generation of human lymphokine-activated killer cells: early inducation of interleukin 1β by interleukin 2;Kovacs;Cancer Res,1989
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献